Home

Tempus AI, Inc. - Class A Common Stock (TEM)

69.29
+7.44 (12.03%)

Tempus AI, Inc. is a technology company focused on leveraging artificial intelligence to revolutionize the healthcare industry

The company specializes in developing data-driven solutions that provide advanced analytics and insights for precision medicine, enhancing patient care by integrating clinical and molecular data. Tempus works with healthcare providers, researchers, and pharmaceutical companies to streamline the process of matching patients with tailored treatments, ultimately aiming to improve health outcomes and accelerate advancements in medical research. By harnessing the power of machine learning and vast datasets, Tempus is at the forefront of transforming healthcare practices and fostering innovation in the medical field.

SummaryNewsPress ReleasesChartHistoricalFAQ
Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · February 5, 2025
8 Analysts Have This To Say About Tempus AIbenzinga.com
Via Benzinga · February 5, 2025
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbasebenzinga.com
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSEABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.”
Via Benzinga · February 5, 2025
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · February 4, 2025
Why Tempus Ai Stock Is Skyrocketing Todayfool.com
Via The Motley Fool · January 21, 2025
Beyond The Numbers: 6 Analysts Discuss Tempus AI Stockbenzinga.com
Via Benzinga · January 14, 2025
AI Stocks Are Rallying After The Bell: What's Going On?benzinga.com
Several AI-linked stocks are trading higher in Monday's after-hours session after Palantir Technologies shares rocketed higher on the back of blowout earnings. Here's what you need to know.
Via Benzinga · February 3, 2025
Small- To Mid-Cap Biotech Trades Poised For Gainstalkmarkets.com
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these spaces.
Via Talk Markets · February 1, 2025
The Former Speaker Buys AItalkmarkets.com
TEM is one of the first stocks we can recall that likely rallied significantly because of a Pelosi trade disclosure.
Via Talk Markets · January 31, 2025
Options Corner: Tempus AI Stock Soars On Nancy Pelosi's Call Options — But Should Investors Follow?benzinga.com
Although Nancy Pelosi buying Tempus AI call options is noteworthy, NEM stock is best reserved for advanced volatility traders.
Via Benzinga · January 31, 2025
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.
Via MarketBeat · January 27, 2025
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?benzinga.com
Top performers in last week's mid-cap stocks: Oklo Inc., Tempus AI, Himax Tech, Super Group, NuScale Power, WNS Holdings, Guardant Health, Rigetti Computing.
Via Benzinga · January 26, 2025
MarketBeat Week in Review – 01/20 - 01/24
Stocks surged higher as investors reacted positively to dovish tariff news; next week will be highlighted by the Federal Reserve meeting and some tech earnings
Via MarketBeat · January 25, 2025
Tempus AI Stock Is Up 40% in January. Is It Too Late to Buy?fool.com
Nancy Pelosi disclosed several new stock trades.
Via The Motley Fool · January 23, 2025
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Nowstocktwits.com
A regulatory filing from Wednesday night disclosed that Tempus AI founder and CEO Eric Lefkofsky sold 946,084 shares of Tempus between Jan. 15-17.
Via Stocktwits · January 23, 2025
What's Going On With Tempus AI Shares Wednesday?benzinga.com
Tempus AI Inc (NASDAQTEM) shares are trading higher Wednesday. The stock appears to be moving on continued momentum from Tuesday's session. Here's a look at what you need to know.
Via Benzinga · January 22, 2025
Tempus AI: A Game-Changer in AI-Powered Healthcare
TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock.
Via MarketBeat · January 22, 2025
Pelosi Bets Big on AI: This Is What You Need to Know
Congressional Whale Nancy Pelosi is in the spotlight, buying significant positions in tech stocks like NVDA and other AI plays.
Via MarketBeat · January 22, 2025
TempusAI Stock Surges On AI-Enabled Healthcare App Launch, Pelosi Buy: Retail Mood Stays Buoyantstocktwits.com
TempusAI’s olivia includes features such as smart profile summary, AI-enabled notetaker, medical image sharing, health monitoring and direct data import.
Via Stocktwits · January 21, 2025
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 22, 2025
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · January 21, 2025
Tempus AI Stock Is Trading Higher Tuesday: What's Going On?benzinga.com
Tempus AI Inc (NASDAQTEM) shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position in the technology company.
Via Benzinga · January 21, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 21, 2025
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 21, 2025
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidiabenzinga.com
Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.
Via Benzinga · January 18, 2025